pfizer-inc. - Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,842 +0.87%

DJIA 48,355 +0.93%

Nasdaq 25,100 +0.83%

DAX 23,938 -0.11%

Gold $4,196 +0.16%

Oil $95.65 -1.08%

BTC $72,423 +1.48%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,220 +0.50%

S&P 500 6,842 +0.87%

DJIA 48,355 +0.93%

Nasdaq 25,100 +0.83%

DAX 23,938 -0.11%

Gold $4,196 +0.16%

Oil $95.65 -1.08%

BTC $72,423 +1.48%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,220 +0.50%

pfizer-inc.

Pfizer Lyme vaccine vial and syringe symbolizing over 70% efficacy Phase 3 VALOR data

Pharma & Healthcare·Stocks·USA

Pfizer Lyme vaccine 70% efficacy Shock as PFE slips

By Maik Kemper • Mar 23, 2026

Pfizer Lyme vaccine vial and syringe symbolizing over 70% efficacy Phase 3 VALOR data

Pharma & Healthcare·Stocks·USA

Pfizer Lyme vaccine 70% efficacy Shock as PFE slips

By Maik Kemper • Mar 23, 2026

Can the Pfizer Lyme vaccine’s >70% efficacy data revive sentiment around PFE just as investors write off its post-COVID growth story? Maik Kemper Editor in…